MULTI-STAGE PERSONALIZED LONGEVITY THERAPEUTICS

CD147 CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

METHODS FOR REDUCING CARDIOVASCULAR RISK

Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancer

TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

Antagonistic CD40 monoclonal antibodies and uses thereof

CD30-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCERS

Anti-PD-L1 antibodies and variants

ANTI-VISTA ANTIBODIES AND FRAGMENTS

Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28

TARGETING REGULATORY B CELLS AND THEIR REGULATORS FOR CANCER IMMUNOTHERAPY

CONDITIONALLY ACTIVATED BINDING PROTEINS CONTAINING Fc REGIONS AND MOIETIES TARGETING TUMOR ANTIGENS

CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind CD3 and CD20, and Uses Thereof

PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES

LILRB4-binding antibody and methods of use thereof

TREATMENT OF CANCER METASTASIS BY TARGETING EXOSOME PROTEINS

ILT7 binding molecules and methods of using the same

IDENTIFICATION AND TARGETING OF TUMOR PROMOTING CARCINOMA ASSOCIATED FIBROBLASTS FOR DIAGNOSIS AND TREATMENT OF CANCER AND OTHER DISEASES

PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY AGAINST IL-5 AND USE THEREOF

Humanized anti-IL17A antibody and application thereof

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

Humanized anti-VEGF monoclonal antibody

Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor

METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY

Muscle targeting complexes and uses thereof for treating dystrophinopathies

INTERNALIZING BINDING MOLECULES TARGETING RECEPTORS INVOLVED IN CELL PROLIFERATION OR IN CELL DIFFERENTIATION

Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic amino acid comprising a phenyl or an indole

ANTI-HER2 BISPECIFIC ANTIBODY AND APPLICATION THEREOF

Methods of blood screening

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal

METHOD FOR TREATING A DEGENERATIVE NEUROLOGICAL DISORDERS COMPRISING ADMINISTERING ASM INHIBITOR

ANTI-MERTK ANTIBODIES AND THEIR METHODS OF USE

J591 MINIBODIES AND CYS-DIABODIES FOR TARGETING HUMAN PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND METHODS FOR THEIR USE

NOVEL CD40-BINDING ANTIBODIES

METHODS AND COMPOSITIONS RELATING TO CHEMOKINE RECEPTOR VARIANTS

FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE

BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28

Anti-ICOS Antibodies for the Treatment of Cancer

Antibodies to programmed cell death protein 1

CD47 antibodies and uses thereof for treating cancer

METHODS AND COMPOSITIONS FOR TREATING MAST CELL GASTRITIS, MAST CELL ESOPHAGITIS, MAST CELL ENTERITIS, MAST CELL DUODENITIS, AND/OR MAST CELL GASTROENTERITIS

Methods for Treating Psoriasis Using an Anti-IL-23 Antibody

THERAPEUTIC COMBINATIONS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (II)

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR

Monoclonal antibodies against alpha-synuclein fibrils

TREATMENT OF NEONATAL HYPOXIA INCLUDING IMPAIRMENTS OR EFFECTS THEREOF

ANTIBODIES TARGETING C5AR

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER

ANTI-CD40 ANTIBODIES AND USES THEREOF

METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

Methods for treating tumor-induced osteomalacia

Notch receptors with hinge domain

FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE

TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS

APOE GENOTYPING IN CANCER PROGNOSTICS AND TREATMENT

TCR FUSION PROTEIN AND CELL EXPRESSING TCR FUSION PROTEIN

Anti-Dectin-1 antibodies and methods of use thereof

Anti-CD94 antibodies and methods of use thereof

USE OF ANTI-CTLA-4 ANTIBODIES WITH ENHANCED ADCC TO ENHANCE IMMUNE RESPONSE TO A VACCINE

TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/LAG-3, PREPARATION METHOD THEREFOR, AND USE THEREOF

TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1/TGF-beta, PREPARATION METHOD THEREFOR, AND USE THEREOF

TETRAVALENT BISPECIFIC ANTIBODY AGAINST PD-1 AND VEGF, PREPARATION METHOD THEREFOR, AND USE THEREOF

Anti-Vβ17/anti-CD123 bispecific antibodies

Anti-CD47 antibodies and uses thereof

TREM2 ANTIBODIES AND USES THEREOF

ANTIBODIES TARGETING CDH19 FOR MELANOMA

ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF

Interleukin-31 monoclonal antibodies for veterinary use

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETING IL-17A, AND METHODS OF USE THEREOF

ANTI-SEMA3A ANTIBODIES AND THEIR USES FOR TREATING A THROMBOTIC DISEASE OF THE RETINA

Motile sperm domain containing protein 2 antibodies and methods of use thereof

A METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CANCER BY TARGETING THE EXTRACELLULAR PORTION OF KERATIN 14 (KRT14) RESIDING ON CANCER CELLS

Decreasing infections in colonized patients

Anti-Viroporin Antibodies and Methods of Treating COVID-19

ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMMUNOREGULATION

Hemiasterlin derivative and antibody-drug conjugate thereof

Methods of administering anti-IL31A antibody-containing formulations

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

MESOTHELIN CARS AND USES THEREOF

METHODS FOR IMPROVING THE EFFICACY OF A SURVIVIN THERAPEUTIC IN THE TREATMENT OF TUMORS

METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE

UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY

Trispecific and/or trivalent binding proteins

Antibody and functional fragment thereof

CDCP1-TARGETED THERAPIES

Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma

ANTI-CD40 ANTIBODIES AND THEIR USES

FULLY HUMANIZED ANTI-GITR ANTIBODY AND PREPARATION METHOD THEREFOR

FC BINDING FRAGMENTS COMPRISING A CD137 ANTIGEN-BINDING SITE

ST2 antigen binding proteins

AGONISTIC TRKB BINDING MOLECULES FOR THE TREATMENT OF EYE DISEASES

Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases

HETERODIMERIC FC-FUSED PROTEINS

USE OF INTEGRIN INHIBITORS FOR TREATMENT OR PREVENTION OF A NEUROLOGICAL IMMUNITY DISORDER AND/OR NERVOUS SYSTEM INJURY

Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers

Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Anti-TREM2 antibodies and methods of use thereof

Antibodies to MAdCAM

Anti-CD47 antibody and application thereof

SIRP1α targeted chimeric proteins and uses thereof

Use for preventing and treating myeloid-derived suppressor cell-related diseases

ANTI-TGFB ANTIBODIES AND THERAPEUTIC USES THEREOF

ANTI-POLYETHYLENE GLYCOL (PEG) ANTIBODY MOUSE MODEL FOR RIGOROUS ASSESSMENT OF PEG-BASED THERAPIES: ADJUVANT-FREE INDUCTION MODEL

Antibodies to human complement C2B

Medicinal composition containing monoclonal antibody or antibody fab fragment thereof, and use thereof

PATHOGEN BINDING PROTEINS

Monoclonal antibodies specific for the PB2 antigen of the human influenza A virus (flu), nucleotide sequences, method and diagnostic kit for flu infection

Compositions for preventing or treating viral and other microbial infections

TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

HALF-LIFE EXTENDED IMMTAC BINDING CD3 AND A HLA-A*02 RESTRICTED PEPTIDE

MODULATION OF DENDRITIC CELL LINEAGES

CD38 Antibody Drug Conjugate

Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine

ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY ENGINEERED T CELLS TARGETING CD19

Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody

COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING MANASSANTIN A AND IMMUNE CHECKPOINT INHIBITOR OR EPITHELIAL GROWTH FACTOR RECEPTOR INHIBITOR

GENE EXPRESSION BASED BIOMARKER OF TUMOR RESPONSE TO PD-1 ANTAGONISTS

ANTI-OX40 ANTIBODIES AND THEIR USES

Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma

HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

Methods Of Treating Type 2 Diabetes Mellitus Using Glucagon Receptor Antagonistic Antibodies

Antigen-binding proteins that activate the leptin receptor

SINGLE DOMAIN ANTIBODIES AGAINST CLL-1

CD1a antibodies and uses thereof

Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

ANTIGEN BINDING MOLECULES AND EPITOPES, AND USES THEREOF

ANTIBODIES SPECIFIC TO HUMAN NECTIN-2

METHODS FOR REDUCING POST-OPERATIVE COGNITIVE DYSFUNCTION (POCD)

Compositions and methods for targeting activin signaling to treat cancer

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

Anti-CGRP Antibody Formulation

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER

DNA Antibody Constructs And Method Of Using Same

Immune tolerant elastin-like peptide tetramer guided nanoparticles and methods of use

BIFUNCTIONAL MOLECULES WITH IL-7 ACTIVITY

Low-dose radiation therapy for traumatic brain injury and stroke

ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF

FORMULATIONS OF ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF

CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY

POLYMERIC NANOVACCINES AND USES THEREOF

TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS

METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

Anti-ANGPTL 3/8 complex antibodies and methods of using the same

Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof

Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof

MULTIMERIC CD40 BINDING MOLECULES AND USES THEREOF

Multivalent and multispecific OX40-binding fusion proteins

Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof

Method of treating asthma with anti-IL1RAP antibodies

Antitumor Agent

Anti-CD147 antibody

ANTI-NGF ANTIBODIES AND METHODS OF USE THEREOF

MULTI-TARGETING FUSION PROTEIN FOR BLOCKING THE GROWTH OF VASCULAR ENDOTHELIAL CELLS AND ACTIVATING T CELLS AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS

ANTIBODIES TO PYROGLUTAMATE AMYLOID-B AND USES THEREOF

14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis

IL-10 VARIANT MOLECULES AND METHODS FOR TREATING INFLAMMATORY DISEASE AND ONCOLOGY

NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF

COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

Ii vaccine adjuvant

PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION

Gene expression markers and treatment of multiple sclerosis

ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER

DNA-ENCODED BISPECIFIC T-CELL ENGAGERS TARGETING CANCER ANTIGENS AND METHODS OF USE IN CANCER THERAPUTICS

High affinity monoclonal antibodies targeting glypican-1 and methods of use

CD47 targeted therapies for the treatment of infectious disease

Monoclonal antibody targeting a unique sialoglycosylated cancer-associated epitope of CD43

SENOLYTIC CAR-T CELLS TARGETING UPAR, A CELL SURFACE AND SECRETED SENESCENCE BIOMARKER

Methods for treating nephrotic syndrome

ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD40 ANTIBODIES FOR USE IN TREATMENT OF HIDRADENITIS

Use of LEPR Agonists for Pain

ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

FLT3 BINDING PROTEINS AND METHODS OF USE

ANTI-ALK2 ANTIBODIES AND USES THEREOF

ANTI-PD-1 ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND PHARMACEUTICAL USE THEREOF

METHODS FOR ENHANCING IMMUNOSUPPRESSIVE THERAPY BY MULTIPLE ADMINISTRATION OF ALPHA BETA TCR-BINDING POLYPEPTIDE

SH3YL1 antibodies, compositions comprising the same, and vectors and uses thereof

THERAPEUTIC TARGET AND MONOCLONAL ANTIBODIES AGAINST IT FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

METHODS OF TREATING ALZHEIMER'S DISEASE

TREATING REFRACTORY MIGRAINE

RSV-specific antibodies and functional parts thereof

ACE2- and TMPRSS2-Targeted Compositions and Methods for Treating COVID-19

Chimeric engulfment receptor molecules

ANTIBODY-TUMOR NECROSIS FACTOR alpha FUSION PROTEIN AND ITS PREPARATION AND APPLICATIONS

COMPOSITIONS FOR THE TREATMENT OF DISEASE

CONJUGATE COMPRISING LIGAND AND CEACAM5 ANTIBODY FAB FRAGMENT

BELANTAMAB MAFODOTIN IN COMBINATION WITH PEMBROLIZUMAB FOR TREATING CANCER

mRNA combination therapy for the treatment of cancer

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

MODIFIED IMMUNE CELLS EXPRESSING FLAGELLIN POLYPEPTIDE

Modified Cell Expansion and Uses Thereof

SALT NANOPARTICLES AND COMPOSITIONS AND METHODS OF USE THEREOF

Human papilloma virus as predictor of cancer prognosis

COMBINATION PRODUCT FOR THE TREATMENT OF CANCER

IDENTIFICATION OF PATIENTS IN NEED OF PD-L1 INHIBITOR COTHERAPY

CAR T CELL METHODS AND CONSTRUCTS

Antibodies for Botulinum Neurotoxins

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

KLOTHO BETA

NOVEL HUMANIZED ANTIBODIES AGAINST FACTOR XI HAVING ANTI-THROMBOTIC AND ANTI-INFLAMMATORY EFFECT AND USES THEREOF

HER2/neu-specific antibodies and methods of using same

Anti-glyco-MUC1 antibodies and their uses

Targeting intracellular target-binding determinants with intracellular antibodies

MULTI-SPECIFIC PROTEIN MOLECULES AND USES THEREOF

Antibody molecules to C5aR1 and uses thereof

Monoclonal antibody that specifically binds to CD20

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND METHODS OF USE

USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF INFLAMMATORY CONDITIONS

ANTI-CD137L ANTIBODIES AND METHODS OF USING SAME

THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR MODULATING CELLULAR INTERNALIZATION

Anti-EGFR combinations for treating tumors

ANTI-INTEGRIN BETA-1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF

TIM-3 ANTIBODIES AND COMBINATIONS WITH OTHER CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER

Antibodies Directed Against Programmed Death-1 (PD-1)

NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION

Methods and compositions for modulating beta chain mediated immunity

ANTIGEN BINDING CONSTRUCTS TO TARGET MOLECULES

Antigen binding proteins

Anti-CD47 monoclonal antibody and use thereof

HETERODIMERIC FUSION PROTEIN

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

METHODS OF NEUTRALIZING IL-8 BIOLOGICAL ACTIVITY

Treatment of non-alcoholic steatohepatitis (NASH) with IL-27 antibody

METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3

Protein binding to fibronectin B domain

Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof

ANTI-ELASTIN ANTIBODIES AND METHODS OF USE

Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders

HUMANIZED AND STABILIZED FC5 VARIANTS FOR ENHANCEMENT OF BLOOD BRAIN BARRIER TRANSPORT

Anti-galactofuranose antibodies for detecting and treating aspergillosis

Antibodies against clostridium difficile toxins and methods of using the same

RED BLOOD CELL TARGETED FACTOR VIII AND METHOD OF USING THE SAME

BI-AND TRI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF

Anti-BCMA chimeric antigen receptors

Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof

Methods and compositions for antibody-evading virus vectors

Anti-PD-L1 diabodies and the use thereof

Actinium-225 and checkpoint inhibitor combination therapy

GLYCOENGINEERED ANTIBODY DRUG CONJUGATES

Means and Methods for Treating Tumorous Diseases

COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB

Compositions and methods for conjugating activatable antibodies

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

COMBINED SPHERICAL NUCLEIC ACID AND CHECKPOINT INHIBITOR FOR ANTITUMOR THERAPY

SARS-CoV-2 subunit vaccine and microneedle array delivery system

Anti-TMPRSS2 antibodies and antigen-binding fragments

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

ANTI-CD40 BINDING MOLECULES HAVING ENGINEERED FC DOMAINS AND THERAPEUTIC USES THEREOF

Anti-BCMA antibody-drug conjugates and methods of use

Anti-IL-4R antibody and use thereof

METHODS AND COMPOSITIONS FOR REDUCING NUMBERS OR ELIMINATING HIV-INFECTED CELLS

USE OF AGENTS CAPABLE OF INDUCING LC3-ASSOCIATED PHAGOCYTOSIS FOR TREATING SUSTAINED INFLAMMATION IN PATIENTS SUFFERING FROM CHRONIC LIVER DISEASE

ANTI-TIM-3 ANTIBODIES

USE OF ANTI-CEACAM5 IMMUNOCONJUGATES FOR TREATING LUNG CANCER

Human monoclonal antibodies to Isd proteins and uses thereof

MIXED BINDING DOMAINS

INFLUENZA VACCINES AND METHODS OF USE THEREOF

APPLICATION OF PCSK9 INHIBITORS IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

Claudin18.2 binding moieties and uses thereof

METHODS OF USING SURUFATINIB IN TREATING ADVANCED PANCREATIC AND EXTRA-PANCREATIC NEUROENDOCRINE TUMORS

CD133-BINDING AGENTS AND USES THEREOF

Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCERS RESISTANT TO IMMUNE CHECKPOINT THERAPY

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

NOVEL POLYPEPTIDES

NOVEL AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

Anti-mullerian hormone receptor binding peptides

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses

Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum

Binding proteins and methods of use thereof

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

DNA MONOCLONAL ANTIBODIES TARGETING PD-1 FOR THE TREATMENT AND PREVENTION OF CANCER

ACTIVATABLE MASKED ANTI-CTLA4 BINDING PROTEINS

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

SEMA4D antibody, preparation method therefor and use thereof

HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF

CLAZAKIZUMAB IN THE TREATMENT OF CHRONIC ANTIBODY-MEDIATED REJECTION OF ORGAN TRANSPLANT

IL-6 binding molecules

Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody

Antibodies with improved stability to intestinal digestion, polynucleotides thereof and methods of use thereof to treat disease

Use of anti-FAM19A5 antibodies for treating fibrosis

METHODS FOR TREATING DISEASE USING PSMP ANTAGONISTS

ANTAGONISTS

METHOD FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Modification of Antibody FcRn binding

Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains

Novel Methionine Containing Antibodies for Conjugation of Agents